nodes	percent_of_prediction	percent_of_DWPC	metapath
Levocabastine—NTSR2—midbrain—Gilles de la Tourette syndrome	0.152	0.29	CbGeAlD
Levocabastine—NTSR2—nervous system—Gilles de la Tourette syndrome	0.125	0.239	CbGeAlD
Levocabastine—NTSR2—central nervous system—Gilles de la Tourette syndrome	0.12	0.23	CbGeAlD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.105	0.22	CbGpPWpGaD
Levocabastine—NTSR2—brain—Gilles de la Tourette syndrome	0.0954	0.182	CbGeAlD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0173	0.0362	CbGpPWpGaD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0168	0.0351	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0159	0.0333	CbGpPWpGaD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0156	0.0327	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0148	0.031	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0144	0.0301	CbGpPWpGaD
Levocabastine—NTSR2—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.0141	0.0296	CbGpPWpGaD
Levocabastine—HRH1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0136	0.0284	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0134	0.028	CbGpPWpGaD
Levocabastine—HRH1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0132	0.0276	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0127	0.0265	CbGpPWpGaD
Levocabastine—HRH1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0123	0.0257	CbGpPWpGaD
Levocabastine—HRH1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0114	0.0239	CbGpPWpGaD
Levocabastine—HRH1—nervous system—Gilles de la Tourette syndrome	0.0113	0.0216	CbGeAlD
Levocabastine—NTSR2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0113	0.0236	CbGpPWpGaD
Levocabastine—HRH1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0111	0.0232	CbGpPWpGaD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0109	0.0229	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0109	0.0229	CbGpPWpGaD
Levocabastine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.0109	0.0208	CbGeAlD
Levocabastine—HRH1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0103	0.0216	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0102	0.0213	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00937	0.0196	CbGpPWpGaD
Levocabastine—HRH1—brain—Gilles de la Tourette syndrome	0.00862	0.0165	CbGeAlD
Levocabastine—HRH1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00859	0.018	CbGpPWpGaD
Levocabastine—HRH1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00722	0.0151	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00713	0.015	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00636	0.0133	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00618	0.0129	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00578	0.0121	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00576	0.0121	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00561	0.0118	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00523	0.011	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00403	0.00845	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00366	0.00767	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00341	0.00716	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00331	0.00695	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00309	0.00647	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00262	0.00549	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00254	0.00533	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00237	0.00496	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00224	0.0047	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00218	0.00456	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00216	0.00453	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00215	0.0045	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00203	0.00425	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00192	0.00402	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00171	0.00358	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00166	0.00348	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00166	0.00348	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00154	0.00324	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00142	0.00298	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00108	0.00227	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000965	0.00202	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000937	0.00196	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000877	0.00184	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000873	0.00183	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000851	0.00178	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000793	0.00166	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000611	0.00128	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000555	0.00116	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000518	0.00109	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000503	0.00105	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000468	0.000982	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000328	0.000688	CbGpPWpGaD
